| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $13.97M | - | |
| CEO | 143.1K | $1.51M | - | |
| Other | 52.0K | $549.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 8, 2018 | Porter Derrell | SVP, Head Of Global Commercial | Sell | 1,544 | $40.15 | $61,991.60 | -11.0% | |
| Apr 27, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 8,800 | $42.46 | $373,659.00 | -1.1% | |
| Apr 12, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 8,800 | $41.87 | $368,472.00 | -1.1% | |
| Mar 29, 2018 | Clark Mitchall G. | EVP &Chief R &Qa Officer | Sell | 22,400 | $40.07 | $897,568.00 | -14.4% | |
| Mar 27, 2018 | Clark Mitchall G. | EVP &Chief R &Qa Officer | Sale+OE | 100,203 | $37.87 | $3,795,061.82 | -8.3% | |
| Mar 27, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 8,800 | $38.59 | $339,549.00 | -0.8% | |
| Mar 26, 2018 | Haqq Christopher | EVP, R&D &Chief Scientific Of | Sell | 18,327 | $39.79 | $729,264.52 | -2.7% | |
| Mar 20, 2018 | McGrath John | EVP &Chief Financial Officer | Sell | 6,000 | $40.41 | $242,460.00 | -3.2% | |
| Mar 16, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 8,800 | $42.13 | $370,748.00 | -1.0% | |
| Mar 12, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 1,000 | $46.31 | $46,314.00 | -0.2% |